Management of arrhythmias in pregnancy relies on general hemodynamic knowledge and a multi-disciplinary approach due to a lack of randomized data.
Answers are grounded in this paper and cite their sources.
Multidisciplinary care remains standard for pregnant arrhythmia patients; leaves open need for randomized trials to refine guidance.
Cardiovascular diseases in pregnancy are the most common causes of maternal mortality in developed world and an important cause of heart failure, stroke, and arrhythmia. Cardiac disease complicates 0.4–4% of all pregnancies, and arrhythmias are among the most common cardiac complications [1]. In some cases, pregnancy triggers exacerbations of pre-existing arrhythmias, whereas in others it may manifest for the first time [2]. A prior history of arrhythmias or structural heart disease and family history of sudden death are the factors that matter to risk of tachyarrhythmias during pregnancy [3]. Due to extraordinary ethical considerations in pregnant women, there are only a few randomized studies and little data on efficacy or safety of antiarrhythmic drugs applied during pregnancy [4]. Therefore, much of clinical care is guided by general knowledge about hemodynamic changes in pregnant women, universal principles of treatment of arrhythmias and finally by gained experience in that area. Multi-disciplinary approach remains the overriding principle in management of pregnant woman with arrhythmias, including collaboration with gynecological and obstetric center. JRCD 2016; 2 (6): 177–180
No takes yet. Share an insight, caveat, or question.
Wiśniowska‐Śmiałek et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: